Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Loss

v3.21.2
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Income Statement [Abstract]        
Revenue $ 2,211 $ 2,264 $ 4,121 $ 3,731
Cost of revenue 919 1,005 1,594 1,835
Gross profit 1,292 1,259 2,527 1,896
Operating expenses:        
Sales and marketing 1,787 1,712 3,580 4,232
Research and development 709 452 1,312 1,163
General and administrative 2,144 1,943 4,122 4,130
Restructuring 0 244 0 244
Total operating expenses 4,640 4,351 9,014 9,769
Loss from operations (3,348) (3,092) (6,487) (7,873)
Other income (expense), net:        
Interest expense (27) (38) (53) (90)
Gain (loss) on revaluation of warrant liabilities 875 (8,574) 886 (6,055)
Warrant issuance expense 0 (329) 0 (329)
Gain on forgiveness of note payable 1,099 0 1,099 0
Other income (expense), net 128 266 (388) 46
Total other income (expense), net 2,075 (8,675) 1,544 (6,428)
Net loss (1,273) (11,767) (4,943) (14,301)
Other comprehensive (loss) income (125) (193) 340 (20)
Comprehensive loss $ (1,398) $ (11,960) $ (4,603) $ (14,321)
Net loss per share applicable to common shareholders, basic (in dollars per share) $ (0.10) $ (1.88) $ (0.42) $ (2.37)
Net loss per share applicable to common shareholders, diluted (in dollars per share) $ (0.11) $ (1.88) $ (0.44) $ (2.37)
Weighted average number of shares outstanding, basic (in shares) 12,655 6,261 11,709 6,032
Weighted average number of shares outstanding, diluted (in shares) 12,737 6,261 11,839 6,032